Healio Podcasts
Recent Episodes
NSAIDs, Part 3: The rise, fall and rise again of COX-2 inhibition
In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of August 19, 2024
In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of July 22, 2024
In this edition, guselkumab brings ‘stringent’ control through 2 years, SARDs outpatient visits result in opioid prescriptions and more.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of June 24, 2024
In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more.
NSAIDs, Part 2: The Dawn of the Anti-Inflammatories
In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of May 20, 2024
In this edition, difficult-to-treat psoriatic arthritis 'not all about the therapies', Samsung biosimilar comparable to etanercept and more.
The Discovery of Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Part 1
Humans have had an insatiable appetite for inhibiting production of prostaglandins for centuries! This series delves into the history of aspirin and NSAIDs, looking at the understanding of the prostaglandin pathway.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of April 22, 2024
In this edition, FDA approves Selarsdi as Stelara biosimilar, deucravacitinib improves ‘broad range’ of patient-reported outcomes and more.
Urticarial Vasculitis, Part 2: Walking the Balance Beam of Allergy and Rheumatology
This episode digs into the pathophysiology of urticaria vasculitis from anti-C1q to the story of bradykinin.
Urticarial Vasculitis: Attack of the Nettles, Part 1
Is it an allergy or an autoimmune vasculitis, or a little of both? Find out the story of urticarial vasculitis, how this disease was recognized and eventually sorted out from other types of urticaria.
NSAIDs, Part 3: The rise, fall and rise again of COX-2 inhibition
In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of August 19, 2024
In this edition, drug discounts through Medicare price negotiations, opioid use has fallen 15% annually since 2014 and more.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of July 22, 2024
In this edition, guselkumab brings ‘stringent’ control through 2 years, SARDs outpatient visits result in opioid prescriptions and more.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of June 24, 2024
In this edition, extensive psoriasis and IBD history predict difficult-to-treat psoriatic arthritis, targeted therapies demonstrate low risk for serious infection and more.
NSAIDs, Part 2: The Dawn of the Anti-Inflammatories
In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of May 20, 2024
In this edition, difficult-to-treat psoriatic arthritis 'not all about the therapies', Samsung biosimilar comparable to etanercept and more.
The Discovery of Non-Steroidal Anti-inflammatory Drugs (NSAIDs), Part 1
Humans have had an insatiable appetite for inhibiting production of prostaglandins for centuries! This series delves into the history of aspirin and NSAIDs, looking at the understanding of the prostaglandin pathway.
Healio Minute Podcast, Rheumatology/Psoriatic Arthritis Edition: Top Headlines - Week of April 22, 2024
In this edition, FDA approves Selarsdi as Stelara biosimilar, deucravacitinib improves ‘broad range’ of patient-reported outcomes and more.
Urticarial Vasculitis, Part 2: Walking the Balance Beam of Allergy and Rheumatology
This episode digs into the pathophysiology of urticaria vasculitis from anti-C1q to the story of bradykinin.
Urticarial Vasculitis: Attack of the Nettles, Part 1
Is it an allergy or an autoimmune vasculitis, or a little of both? Find out the story of urticarial vasculitis, how this disease was recognized and eventually sorted out from other types of urticaria.